Steven Branco (@sagustin) profile picture

Focused on healthcare analytics. #bigdata #healthit #healthcareanalytics #datascience #artificialintelligence #ai. Columbia Business School alum @Columbia_Biz

Joined January 2009
Photo by Steven Branco (@sagustin)
Steven Branco retweeted
New government estimates show 92% of people in the U.S. had health coverage in 2022, the highest level ever. But, that may be as close as we get to universal coverage for some time, since pandemic enrollment protections in Medicaid are now unwinding. cms.gov/data-research/statis…
2
39
4
48
9,073
Steven Branco retweeted
Top Trends of 2023: EU pharma reform seeks to provide equitable access; threatens data exclusivity, incentives bioworld.com/articles/704117 #biotech #pharma
1
623
Steven Branco retweeted
More than 81K people died of drug overdoses in the US June 2019—May 2020, a record-breaking number that @CDCgov suggested is related to the #COVID19 pandemic, largely due to synthetic opioid use (ie, illicit #fentanyl) ja.ma/370dxAS @jamahealthforum @jamapsych
7
20
6
30
Online first: #Endoscopic #surgery compared with intensity-modulated #radiotherapy in resectable locally recurrent #nasopharyngealcarcinoma: a randomised, controlled, phase 3 trial thelancet.com/journals/lanon… #HeadNeckCancer
Contents of FDA Refuse-to-File Letters for New Drug Applications and Their Public Disclosure by Applicants ja.ma/3k018Cn #onlinefirst
Point estimate from Phase 3 study: 94% relative risk reduction Point estimate from real-world data: 94% Not too shabby, @pfizer @BioNTech_Group 👏🏽👌🏽
Israel's largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer's vaccine in the country's biggest study to date.​ reuters.com/article/us-healt…
2
14
94
We’re celebrating #WomenInScience today! Follow along to find out what inspired some of our female scientists to pursue a career in #STEM and how they inspire the next generation of women to do the same.
4
10
FDA’s Office of Pharmaceutical Quality (OPQ) issued their 2020 Annual Report. The report covers their challenges & accomplishments in 2020 as they worked to assure the nation had access to safe, effective, quality medicines during the #COVID19 pandemic. go.usa.gov/xsCuR
1
8
1
13
Steven Branco retweeted
Opinion: As the world grapples with a stream of new coronavirus variants, we should not lose sight of the larger implications of naming diseases and the pathogens that cause them. Call them by their scientific names. buff.ly/3aOsNSK
6
5
17
Steven Branco retweeted
Janssen announces positive Phase III results for prostate cancer drug apalutamide bit.ly/3jyBkgz
3
7
Steven Branco retweeted
FDA approves Sanofi's Libtayo for advanced basal cell carcinoma bit.ly/2LGoobY
1
2
Steven Branco retweeted
STAT built its own database by combing through and compiling data from hundreds of documents, including summaries filed by manufacturers to the FDA that outline the intended use and technical specifications of each product. buff.ly/2YSC6LH
1
4
Steven Branco retweeted
As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness buff.ly/3aJw7OH
4
11
Steven Branco retweeted
U.S. regulators have approved more than 160 medical AI products in recent years based on widely divergent amounts of clinical data and without requiring manufacturers to publicly document testing on patients of different genders, races, and geographies. buff.ly/3tuRA6F
1
8
2
16
Steven Branco retweeted
Today we announce that Ken Frazier, Chairman & CEO, will retire as CEO June 30, 2021. Rob Davis, our current EVP, Global Services & CFO, will become CEO and a member of the board of directors, July 1, 2021. Mr. Frazier will continue as executive chairman. merck.us/3cGsOe0
6
42
14
119
Steven Branco retweeted
How can MSLs drive engagement with KOLs? In this white paper, ZS Principal Sunil John shares a data-driven engagement framework to help #pharma companies adapt to the changes in their industry. bit.ly/2LL4L2r
Steven Branco retweeted
How can MSLs drive engagement with KOLs? In this white paper, ZS Principal Sunil John shares a data-driven engagement framework to help #pharma companies adapt to the changes in their industry. bit.ly/2LL4L2r #medicalaffairs